Science ❯ Medicine

Pharmacology

Drug Development Hormones Opioids Therapeutics Drug Treatment Antibiotics Drug Efficacy and Side Effects Obesity Treatment Drugs Birth Control Pills Contraceptive Medication Contraceptive Effectiveness Cannabis Drug Research Alzheimer's Disease Treatment Antibiotic Resistance Reproductive Health Toxinology Pain Relief Hormonal Therapies Safety Studies Hormonal Contraceptives Indian Pharmacology Acetaminophen Medications Clinical Research Hormonal Treatments GLP-1 Drugs Drug Delivery Systems Drug Efficacy Historical Pharmacology Endocrinology A3 Adenosine Receptor Agonists GLP-1 Receptor Agonists Obesity Treatment Vaccinology Biologics Anesthetic Drugs Efficacy Studies

Can-Fite's Namodenoson Clears Phase IIa Safety Bar in Pancreatic Cancer

Efficacy results remain immature with survival follow-up ongoing.

Eupraxia Reports Early EoE Trial Data With Near‑Normal Tissue at Top Dose

Mount Sinai's V2P AI Predicts Disease Type From Genetic Mutations

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

Exicure’s Burixafor Delivers About 90% Stem-Cell Mobilization in Phase 2 as Shares Surge

Bayer Stroke Drug Asundexian Hits Phase III Goals, Shares Jump

Cambridge Scientists Grow Self-Organising ‘Hematoids’ That Produce Human Blood Stem Cells

FDA Backs Leucovorin for Cerebral Folate Deficiency as White House Promotes Autism Use

OTC Birth Control Tied to Major Uptake Gains in First Year, National Study Finds

Etienne-Emile Baulieu, Inventor of RU-486, Dies at 98

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies